These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27811861)

  • 41. The current landscape of clinical exome and genome reanalysis in the U.S.
    Frees M; Carter JN; Wheeler MT; Reuter C
    J Genet Couns; 2024 Sep; ():. PubMed ID: 39285507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Taming the genome: towards better genetic test interpretation.
    Caleshu C; Ashley EA
    Genome Med; 2016 Jun; 8(1):70. PubMed ID: 27324065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.
    Boardman F; Hale R
    Mol Genet Genomic Med; 2018 Nov; 6(6):1079-1096. PubMed ID: 30370638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exome and Genome Sequencing and Parallels in Radiology: Searching for Patient-Centered Management of Incidental and Secondary Findings.
    Kang SK; Spector-Bagdady K; Caplan AL; Braithwaite RS
    J Am Coll Radiol; 2016 Dec; 13(12 Pt A):1467-1472. PubMed ID: 27595197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The challenge of comprehensive and consistent sequence variant interpretation between clinical laboratories.
    Pepin MG; Murray ML; Bailey S; Leistritz-Kessler D; Schwarze U; Byers PH
    Genet Med; 2016 Jan; 18(1):20-4. PubMed ID: 25834947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular genetic testing in the United States: comparison with international practice.
    McGovern MM; Elles R; Ronchi E; Boone J; Lubin IM
    Genet Test; 2008 Jun; 12(2):187-93. PubMed ID: 18407746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.
    Davies KD; Farooqi MS; Gruidl M; Hill CE; Woolworth-Hirschhorn J; Jones H; Jones KL; Magliocco A; Mitui M; O'Neill PH; O'Rourke R; Patel NM; Qin D; Ramos E; Rossi MR; Schneider TM; Smith GH; Zhang L; Park JY; Aisner DL
    J Mol Diagn; 2016 Jul; 18(4):572-9. PubMed ID: 27155050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A framework for reporting secondary and incidental findings in prenatal sequencing: When and for whom?
    Vears D; Amor DJ
    Prenat Diagn; 2022 May; 42(6):697-704. PubMed ID: 35032068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laboratory policies and practices for the genetic testing of children: a survey of the Helix network.
    Wertz DC; Reilly PR
    Am J Hum Genet; 1997 Nov; 61(5):1163-8. PubMed ID: 9345088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A framework for the evaluation and reporting of incidental findings in clinical genomic testing.
    Brown CM; Amendola LM; Chandrasekhar A; Hagelstrom RT; Halter G; Kesari A; Thorpe E; Perry DL; Taft RJ; Coffey AJ
    Eur J Hum Genet; 2024 Jun; 32(6):665-672. PubMed ID: 38565640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hereditary cancer gene panel test reports: wide heterogeneity suggests need for standardization.
    Makhnoon S; Shirts BH; Bowen DJ; Fullerton SM
    Genet Med; 2018 Nov; 20(11):1438-1445. PubMed ID: 29493582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing the ethical challenges of next-generation sequencing in genomic medicine.
    Clarke AJ
    Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias.
    Seneca S; Morris MA; Patton S; Elles R; Sequeiros J
    Eur J Hum Genet; 2008 Aug; 16(8):913-20. PubMed ID: 18301445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics.
    Acmg Board Of Directors
    Genet Med; 2017 Jul; 19(7):721-722. PubMed ID: 28055021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laboratory medicine handoff gaps experienced by primary care practices: A report from the shared networks of collaborative ambulatory practices and partners (SNOCAP).
    West DR; James KA; Fernald DH; Zelie C; Smith ML; Raab SS
    J Am Board Fam Med; 2014; 27(6):796-803. PubMed ID: 25381077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practices and policies of clinical exome sequencing providers: analysis and implications.
    Jamal SM; Yu JH; Chong JX; Dent KM; Conta JH; Tabor HK; Bamshad MJ
    Am J Med Genet A; 2013 May; 161A(5):935-50. PubMed ID: 23610049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing.
    Rehder CW; David KL; Hirsch B; Toriello HV; Wilson CM; Kearney HM
    Genet Med; 2013 Feb; 15(2):150-2. PubMed ID: 23328890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidance for laboratories performing molecular pathology for cancer patients.
    Cree IA; Deans Z; Ligtenberg MJ; Normanno N; Edsjö A; Rouleau E; Solé F; Thunnissen E; Timens W; Schuuring E; Dequeker E; Murray S; Dietel M; Groenen P; Van Krieken JH; ;
    J Clin Pathol; 2014 Nov; 67(11):923-31. PubMed ID: 25012948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
    Pujol P; Vande Perre P; Faivre L; Sanlaville D; Corsini C; Baertschi B; Anahory M; Vaur D; Olschwang S; Soufir N; Bastide N; Amar S; Vintraud M; Ingster O; Richard S; Le Coz P; Spano JP; Caron O; Hammel P; Luporsi E; Toledano A; Rebillard X; Cambon-Thomsen A; Putois O; Rey JM; Hervé C; Zorn C; Baudry K; Galibert V; Gligorov J; Azria D; Bressac-de Paillerets B; Burnichon N; Spielmann M; Zarca D; Coupier I; Cussenot O; Gimenez-Roqueplo AP; Giraud S; Lapointe AS; Niccoli P; Raingeard I; Le Bidan M; Frebourg T; Rafii A; Geneviève D
    Eur J Hum Genet; 2018 Dec; 26(12):1732-1742. PubMed ID: 30089825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.